Daniel Ackermann

机构：University Hospital of Bern, University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology, Hypertension Institute · ORCID：0000-0003-0550-354X

发表论文 243 篇 · 总被引 7958 次 · h-index 48

代表论文

• Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis (2022 · Diabetes Care · 被引 207)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 95)
• Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study (2022 · Diabetes Care · 被引 37)
• Increased glucocorticoid metabolism in diabetic kidney disease (2022 · PLoS ONE · 被引 12)
• The urine-to-plasma urea concentration ratio is associated with eGFR and eGFR decline over time in a population cohort (2023 · Nephrology Dialysis Transplantation · 被引 10)
• Adenine-Induced Nephropathy Reduces Atherosclerosis in ApoE Knockout Mice (2022 · Biomolecules · 被引 8)